600721 logo

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Stock Price

SHSE:600721 Community·CN¥3.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600721 Share Price Performance

CN¥8.99
2.42 (36.83%)
CN¥8.99
2.42 (36.83%)
Price CN¥8.99

600721 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
1 Reward

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Key Details

CN¥393.7m

Revenue

CN¥220.3m

Cost of Revenue

CN¥173.5m

Gross Profit

CN¥123.3m

Other Expenses

CN¥50.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 28, 2026
0.13
44.05%
12.75%
0%
View Full Analysis

About 600721

Founded
1959
Employees
578
CEO
Hui Huang
WebsiteView website
www.xjbhc.net

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers biological sample analysis, packaging material compatibility, and base toxic impurity analysis. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.

Recent 600721 News & Updates

Recent updates

No updates